share_log

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Dar Zavain

SEC announcement ·  Apr 3 17:44
Summary by Moomoo AI
Dar Zavain, associated with Recursion Pharmaceuticals, Inc. [RXRX], completed a stock acquisition on April 1, 2024. The transaction involved a grant of 1,467 shares of Class A Common Stock at no cost. Following this transaction, Zavain's direct holdings in the company increased to a total of 89,056 shares. The grant is part of the company's stock-based compensation program and reflects the ongoing investment of key individuals in the company's success.
Dar Zavain, associated with Recursion Pharmaceuticals, Inc. [RXRX], completed a stock acquisition on April 1, 2024. The transaction involved a grant of 1,467 shares of Class A Common Stock at no cost. Following this transaction, Zavain's direct holdings in the company increased to a total of 89,056 shares. The grant is part of the company's stock-based compensation program and reflects the ongoing investment of key individuals in the company's success.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more